Semnur Pharmaceuticals, Inc. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
Semnur Pharmaceuticals, Inc. (SMNR) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of $19.64 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2025-08-15
- Semnur Pharmaceuticals, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-06-30 was $9.87K, a 0.01% decline year-over-year.
- Semnur Pharmaceuticals, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-03-31 was $9.77K, a 1.08% decline year-over-year.
- Semnur Pharmaceuticals, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2024-12-31 was $9.98K, a 0.01% increase year-over-year.
- Semnur Pharmaceuticals, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2024-09-30 was $9.98K.
- Semnur Pharmaceuticals, Inc. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2024 was $39.71K, a 110.35% increase from fiscal 2023.
- Semnur Pharmaceuticals, Inc. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2023 was $18.88K.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2025-06-30 | $9.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15 | $19.64K 10-Q · filed 2025-08-15 | $29.62K derived: sum of 3 quarters · filed 2025-08-15 | $39.60K derived: sum of 4 quarters · filed 2025-08-15 |
| 2025-03-31 | $9.77K 10-Q · filed 2025-05-16 | $19.75K derived: sum of 2 quarters · filed 2025-05-16 | $29.73K derived: sum of 3 quarters · filed 2025-05-16 | $39.60K derived: sum of 4 quarters · filed 2025-08-15 |
| 2024-12-31 | $9.98K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | $19.96K derived: sum of 2 quarters · filed 2025-04-02 | $29.84K derived: sum of 3 quarters · filed 2025-08-15 | $39.71K 10-K · filed 2025-04-02 |
| 2024-09-30 | $9.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | $19.85K derived: sum of 2 quarters · filed 2025-08-15 | $29.73K 10-Q · filed 2024-11-19 | $39.71K derived: sum of 4 quarters · filed 2025-08-15 |
| 2024-06-30 | $9.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15 | $19.75K 10-Q · filed 2025-08-15 | $29.73K derived: sum of 3 quarters · filed 2025-08-15 | |
| 2024-03-31 | $9.87K 10-Q · filed 2025-05-16 | $19.85K derived: sum of 2 quarters · filed 2025-05-16 | ||
| 2023-12-31 | $9.98K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | $18.88K 10-K · filed 2025-04-02 | ||
| 2023-09-30 | $8.90K 10-Q · filed 2024-11-19 |